DV
Dividend Vision

HCWB — HCW Biologics Inc.

HCW Biologics Inc. (HCWB)

Total return is -99.8% over the past 5.1 years, 192.5 points behind SPY at 92.7%. Its deepest 1-year drawdown was 95.5%.

HCW Biologics Inc. is an equity fund that focuses on biologics-related investments within the stock market. With limited publicly available data on its distribution frequency, yield profile, and expense ratio, the fund appears to be in an early stage or carries minimal current income generation. The fund may appeal to investors seeking exposure to the biologics sector, though prospective investors should review current fund documentation for complete details on strategy and costs.

HCWB key facts

Asset type
Stock
Asset class
Equity
Inception date
07/20/2021
Distribution frequency
None
Last close
$2.68
Market cap
$4,670,780
Average volume
130404.0
Beta
2.364
Payout ratio
0.0
Forward P/E
0.0
EPS
$-45.23